Table 2.

Thrombotic events that occurred in 7 of 35 young patients who were treated with anagrelide and followed for up to 15.5 years

PatientEventPlatelet count at time of event (× 109/L)
Cerebrovascular accident 1578 
Transient ischemic attack 688  
Deep vein thrombosis 571  
Thrombophlebitis 424 
Thrombophlebitis 682  
Thrombophlebitis 618 
Cerebrovascular accident 900  
 Deep vein thrombosis 600  
 Deep vein thrombosis 751  
 Pulmonary embolism 973 
PatientEventPlatelet count at time of event (× 109/L)
Cerebrovascular accident 1578 
Transient ischemic attack 688  
Deep vein thrombosis 571  
Thrombophlebitis 424 
Thrombophlebitis 682  
Thrombophlebitis 618 
Cerebrovascular accident 900  
 Deep vein thrombosis 600  
 Deep vein thrombosis 751  
 Pulmonary embolism 973 

or Create an Account

Close Modal
Close Modal